SAGES 指南:代谢与减重手术相关合并症的管理
SAGES 基于 1990 至 2022 年系统综述制定指南,针对减重手术患者的三类合并症问题给出条件性推荐:旁路解剖患者腹腔镜胆囊切除时行常规术中胆管造影、袖状胃切除术后反流先尝试药物管理、炎症性肠病患者优先选择袖状胃切除而非 Roux-en-Y 胃旁路。推荐强度受证据质量限制,并为未来研究指明方向。
要点
- 旁路解剖患者行腹腔镜胆囊切除时,条件性推荐常规术中胆管造影。
- 袖状胃切除术后反流,条件性推荐先药物管理再考虑手术。
- 炎症性肠病患者,条件性推荐袖状胃切除而非 Roux-en-Y 胃旁路。
核心结论
- 对旁路解剖患者腹腔镜胆囊切除、袖状胃切除术后反流及炎症性肠病减重术式三个问题给出条件性推荐。
- 推荐强度受现有证据质量限制,并为所有问题提出未来研究方向。
研究设计与样本
- 系统综述纳入 1990 至 2022 年发表的研究。
- 结果提交减重外科专家组,依据最佳证据或证据缺乏时采用专家意见制定推荐。
主要发现
- 条件性推荐旁路解剖患者腹腔镜胆囊切除时行常规术中胆管造影。
- 条件性推荐袖状胃切除术后反流患者先尝试药物管理再行手术管理。
- 条件性推荐炎症性肠病患者选择袖状胃切除而非 Roux-en-Y 胃旁路。
关键数值与推荐
- 旁路解剖患者腹腔镜胆囊切除:条件性推荐常规术中胆管造影。
- 袖状胃切除术后反流:条件性推荐先药物管理再手术管理。
- 炎症性肠病:条件性推荐袖状胃切除而非 Roux-en-Y 胃旁路。
临床怎么用
- 旁路解剖患者行腹腔镜胆囊切除时考虑常规术中胆管造影。
- 袖状胃切除术后出现反流时先尝试药物管理。
- 炎症性肠病需减重手术时优先考虑袖状胃切除。
局限性
- 推荐强度受现有证据质量限制。
- 部分问题证据基础缺乏,采用专家意见制定推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients who are under consideration for or have undergone metabolic and bariatric surgery frequently have comorbid medical conditions that may make their perioperative care more complex. These recommendations address routine intraoperative cholangiography in patients with bypass-type anatomy, the management of reflux disease after sleeve gastrectomy, and the optimal bariatric procedure for patients with comorbid inflammatory bowel disease. METHODS: A systematic review was conducted including studies published from 1990 to 2022 to address these questions. These results were then presented to a panel of bariatric surgeons who formulated recommendations based on the best available evidence or utilized expert opinion when the evidence base was lacking. RESULTS: Conditional recommendations were made in favor of routine intraoperative cholangiography in patients with bypass-type anatomy undergoing laparoscopic cholecystectomy, trialing medical management prior to surgical management in patients with reflux after sleeve gastrectomy, and sleeve gastrectomy rather than Roux en Y gastric bypass in patients with inflammatory bowel disease. The strength of these recommendations was limited by the quality of evidence available. Recommendations for future research were made for all questions. CONCLUSIONS: These recommendations should provide guidance regarding management of these comorbidities in patients who are under consideration for or have undergone metabolic and bariatric surgery. These recommendations also identify important areas where the future research should focus to strengthen the evidence base.
引用
- Kumar SS, Wunker C, Collings A, et al. SAGES guidelines for the management of comorbidities relevant to metabolic and bariatric surgery. Surg Endosc. 2024. PMID: 39663246. doi:10.1007/s00464-024-11433-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。